Global Cell Therapy Manufacturing Market

View Report Summary
View Report Summary

Global cell therapy manufaturing market is projected to grow at a CAGR of 12% through 2023 to reach USD 6012.09 mn by 2026. Development of advanced therapy can assist in the treatment of fatal chronic diseases including cancer, neurological disorders, among others as well as increasing geriatric population are fueling the growth of the market. Personalized medicine has gained popularity among healthcare workers in recent times owing to better patient response and the highest safety margin to ensure better patient care.

Personalized therapies hold promise for improving health care even at a lower cost. It allows the patient to receive an earlier diagnosis, risk management, and optimal treatment. Global cell therapy manufacturing market is segmented based on therapy, source of cell, scale of operation, source, application and end user and region. Based on the source, market can be bifurcated into contract manufacturing and in-house.

The In-House manufacturing segment is expected to dominate the market in terms of source on account of the presence of large number of companies who have infrastructure and capital to do cell therapy manufacturing. Also, various academic & research institutions have their personalized patient treatment programs, thereby supporting segmental growth. Furthermore, factors such as rising popularity of advanced therapies, increasing prevalence of diseases, among others has increased the demand for cell therapy manufacturing by various companies.

Download Free Sample Report

 

captcha
Letters are not case-sensitive

     ( * Fields are mandatory)